Drug Type Small molecule drug |
Synonyms |
Target |
Action inhibitors |
Mechanism NET inhibitors(Norepinephrine transporter inhibitors), Serotonin reuptake inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC13H20ClNO3 |
InChIKeyHJOCKFVCMLCPTP-UHFFFAOYSA-N |
CAS Registry35604-67-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Sleep Apnea, Obstructive | Phase 2 | United States | 28 Apr 2023 |